Lymphoma Trial, Recruiting (NCT02872987)

Lymphoma Trial, Recruiting NCT02872987 Sponsor: Goethe University Condition: Lymphoma

Printed from Voxsanity (voxsanity.com.au) — NCT02872987 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Lymphoma

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People diagnosed with Acute Lymphoblastic Leukemia (ALL), any subtype, who are being treated following ALL treatment protocols
People with certain other types of leukemia (including NK Cell Lymphoma/Leukemia or Biphenotypic Acute Leukemia) who are being treated following ALL treatment protocols
People with certain types of Non-Hodgkin's Lymphoma — including Burkitt Lymphoma, B Cell Lymphoma, B- or T-lineage Lymphoblastic Lymphoma, Anaplastic Large Cell Lymphoma, or other Non-Hodgkin's Lymphoma — who are being treated following B-ALL treatment protocols
People aged 18 years or older

Who may not be able to join:

No specific exclusion criteria were listed in the official trial information (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 20 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Nicola Gökbuget, Dr. med., University Hospital of Frankfurt (Main)

Phone: +496963016365

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT02872987

Sponsor: Goethe University

Phase: Not Applicable

Status: Recruiting

Condition: Lymphoma

Trial contact: +496963016365

More information: https://clinicaltrials.gov/study/NCT02872987

Eligibility summary (AI generated)

Written by an AI model from the ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People diagnosed with Acute Lymphoblastic Leukemia (ALL), any subtype, who are being treated following ALL treatment protocols
People with certain other types of leukemia (including NK Cell Lymphoma/Leukemia or Biphenotypic Acute Leukemia) who are being treated following ALL treatment protocols
People with certain types of Non-Hodgkin's Lymphoma — including Burkitt Lymphoma, B Cell Lymphoma, B- or T-lineage Lymphoblastic Lymphoma, Anaplastic Large Cell Lymphoma, or other Non-Hodgkin's Lymphoma — who are being treated following B-ALL treatment protocols
People aged 18 years or older

Who may not be able to join:

No specific exclusion criteria were listed in the official trial information (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 20 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Goethe University

Registry

ClinicalTrials.gov

Start date

1 February 2009

Est. completion

1 December 2030

Where this trial is recruiting

🇦🇹 Austria 🇩🇪 Germany

Primary endpoints

Overall survival

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 20 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov